125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

Published:2016 Issue:21 Volume:22 Page:5033
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Hu Peng-Hui,Pan Lan-Hong,Wong Patrick Ting-Yat,Chen Wen-Hui,Yang Yan-Qing,Wang Hong,Xiang Jun-Jian,Xu Meng

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference32 articles.

1. Hepatocellular carcinoma

2. Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma

3. Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma

4. Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy

5. Okada-Ban M, Thiery JP, Jouanneau J. Fibroblast growth factor-2. Int J Biochem Cell Biol 2000;32:263-267.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway;Current Cancer Drug Targets;2023-11-29

2. A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition;International Journal of Immunopathology and Pharmacology;2022-01

3. Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma;Pharmaceuticals;2021-06-29

4. Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs;Frontiers in Cell and Developmental Biology;2020-07-07

5. Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer;Cancers;2019-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3